{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:46:23Z","timestamp":1792215983875,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["113-2314-B-075\\u2212055-MY3"],"award-info":[{"award-number":["113-2314-B-075\\u2212055-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-075-006-MY3"],"award-info":[{"award-number":["110-2314-B-075-006-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jnutbio.2026.110357","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:50:01Z","timestamp":1774396201000},"page":"110357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intestinal epithelial peroxisome proliferator-activated receptor \u03b3 deficiency exacerbates insulin resistance in mice with metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"154","author":[{"given":"Yun-Cheng","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-5425","authenticated-orcid":false,"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jnutbio.2026.110357_bib0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0002","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0003","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jnutbio.2026.110357_bib0004","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jnutbio.2026.110357_bib0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jnutbio.2026.110357_bib0006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jnutbio.2026.110357_bib0007","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI129194","article-title":"The gut microbiome and metabolic syndrome","volume":"129","author":"Dabke","year":"2019","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jnutbio.2026.110357_bib0008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cmet.2015.03.001","article-title":"Regulation of obesity-related insulin resistance with gut anti-inflammatory agents","volume":"21","author":"Luck","year":"2015","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.jnutbio.2026.110357_bib0009","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","article-title":"PPARgamma as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"Dubuquoy","year":"2006","journal-title":"Gut"},{"issue":"6351","key":"10.1016\/j.jnutbio.2026.110357_bib0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science"},{"issue":"6662","key":"10.1016\/j.jnutbio.2026.110357_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","article-title":"Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators","volume":"101","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0013","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4049\/jimmunol.161.2.978","article-title":"Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1","volume":"161","author":"Colville-Nash","year":"1998","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jnutbio.2026.110357_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI7145","article-title":"A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response","volume":"104","author":"Su","year":"1999","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jnutbio.2026.110357_bib0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni1018","article-title":"Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA","volume":"5","author":"Kelly","year":"2004","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jnutbio.2026.110357_bib0016","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0016-5085(03)00262-2","article-title":"A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model","volume":"124","author":"Katayama","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jnutbio.2026.110357_bib0017","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1053\/j.gastro.2007.02.032","article-title":"The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction","volume":"132","author":"Ponferrada","year":"2007","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jnutbio.2026.110357_bib0018","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.dld.2018.04.016","article-title":"Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model","volume":"50","author":"Zhao","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.jnutbio.2026.110357_bib0019","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/gut.2005.081745","article-title":"Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease","volume":"55","author":"Adachi","year":"2006","journal-title":"Gut"},{"issue":"40","key":"10.1016\/j.jnutbio.2026.110357_bib0020","doi-asserted-by":"crossref","first-page":"E5934","DOI":"10.1073\/pnas.1612559113","article-title":"High-fat diet modifies the PPAR-gamma pathway leading to disruption of microbial and physiological ecosystem in murine small intestine","volume":"113","author":"Tomas","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jnutbio.2026.110357_bib0021","doi-asserted-by":"crossref","first-page":"G585","DOI":"10.1152\/ajpgi.00269.2018","article-title":"Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver disease","volume":"316","author":"Lee","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"26","key":"10.1016\/j.jnutbio.2026.110357_bib0022","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","article-title":"Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle","volume":"100","author":"He","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jnutbio.2026.110357_bib0023","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol. Nov"},{"issue":"10","key":"10.1016\/j.jnutbio.2026.110357_bib0024","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200594R","article-title":"(Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis","volume":"36","author":"Hsieh","year":"2022","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2101","article-title":"Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice","volume":"16","author":"Harmon","year":"2010","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jnutbio.2026.110357_bib0026","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0027","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jnutbio.2026.110357_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063983","article-title":"Effect of lipopolysaccharide on inflammation and insulin action in human muscle","volume":"8","author":"Liang","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0029","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41423-021-00639-2","article-title":"Inflammatory processes in the liver: divergent roles in homeostasis and pathology","volume":"18","author":"Ahmed","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0030","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0031","doi-asserted-by":"crossref","first-page":"G1234","DOI":"10.1152\/ajpgi.2001.280.6.G1234","article-title":"iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers","volume":"280","author":"Banan","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0032","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.shk.0000112346.38599.10","article-title":"Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice","volume":"21","author":"Han","year":"2004","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0033","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.102.047308","volume":"305","author":"Banan","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0034","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","article-title":"TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis","volume":"145","author":"Su","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0006-291X(02)00294-2","article-title":"Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation","volume":"293","author":"Kinoshita","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2026.110357_bib0036","doi-asserted-by":"crossref","first-page":"986457","DOI":"10.3389\/fmicb.2022.986457","article-title":"Peroxisome proliferator-activated receptor-gamma as the gatekeeper of tight junction in Clostridioides difficile infection","volume":"13","author":"Lai","year":"2022","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04698-22","article-title":"Disruption of the intestinal mucosal barrier induced by high fructose and restraint stress is regulated by the intestinal microbiota and microbiota metabolites","volume":"11","author":"Yu","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0038","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.chom.2021.04.004","article-title":"Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.jnutbio.2026.110357_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jnutbio.2026.110357_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104821","article-title":"Gut microbiota in the pathogenesis and therapeutic approaches of diabetes","volume":"97","author":"Crudele","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.jnutbio.2026.110357_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071772","article-title":"Desulfovibrio in the Gut: the enemy within?","volume":"11","author":"Singh","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.jnutbio.2026.110357_bib0042","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13099-024-00632-w","article-title":"Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL\/6 mice model","volume":"16","author":"Huang","year":"2024","journal-title":"Gut Pathog"},{"issue":"2","key":"10.1016\/j.jnutbio.2026.110357_bib0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-6941.2002.tb00942.x","article-title":"Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases","volume":"40","author":"Loubinoux","year":"2002","journal-title":"FEMS Microbiol Ecol"},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0044","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.123.063914","article-title":"Streptococcus species abundance in the gut is linked to subclinical coronary atherosclerosis in 8973 participants from the SCAPIS cohort","volume":"148","author":"Sayols-Baixeras","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jnutbio.2026.110357_bib0046","doi-asserted-by":"crossref","first-page":"e3698","DOI":"10.7717\/peerj.3698","article-title":"Genomic and functional analysis of Romboutsia ilealis CRIB(T) reveals adaptation to the small intestine","volume":"5","author":"Gerritsen","year":"2017","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.jnutbio.2026.110357_bib0047","doi-asserted-by":"crossref","first-page":"13424","DOI":"10.1038\/s41598-019-49462-w","article-title":"Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities","volume":"9","author":"Zeng","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2026.110357_bib0048","doi-asserted-by":"crossref","first-page":"992947","DOI":"10.3389\/fnut.2022.992947","article-title":"Bifidobacterium animalis subsp. Lactis MN-Gup protects mice against gut microbiota-related obesity and endotoxemia induced by a high fat diet","volume":"9","author":"Niu","year":"2022","journal-title":"Front Nutr"},{"issue":"11","key":"10.1016\/j.jnutbio.2026.110357_bib0049","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jnutbio.2026.110357_bib0050","doi-asserted-by":"crossref","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","article-title":"Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet","volume":"301","author":"Kamada","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.jnutbio.2026.110357_bib0051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jnutbio.2026.110357_bib0052","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:22:15Z","timestamp":1778779335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286326000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0955286326000999"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110357","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal epithelial peroxisome proliferator-activated receptor \u03b3 deficiency exacerbates insulin resistance in mice with metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110357"}}